Tag: Ocugen

Biotechnology firm Ocugen has announced a fundamental restructuring of its operations, marking a decisive shift in corporate strategy. The company ...

Biotechnology firm Ocugen approaches a pivotal moment that could define its trajectory for the coming year. The company's presentation at ...

Ocugen has achieved a critical regulatory milestone after European Medicines Agency (EMA) officials endorsed the company's development strategy for its ...

In a notable strategic departure, biopharmaceutical firm Ocugen has announced a $5 million equity investment in fellow biotechnology company Carisma ...

Biotechnology firm Ocugen has staged a remarkable recovery, with its share price more than doubling from its annual low of ...

Shares of biotechnology firm Ocugen have captured renewed investor interest after a prolonged period of stagnation. A significant analyst upgrade ...

Recent market analysis reveals a transformative growth trajectory for the retinal biologics sector, a development that could hold significant implications ...

Biotechnology firm Ocugen has generated significant market attention following the release of new clinical trial data for its experimental eye ...